Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

NCT05499832 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Tenecteplase

Sponsor

Insel Gruppe AG, University Hospital Bern